Question 1

I tested positive for antiphospholipid antibodies but haven't had a clot. Do I have antiphospholipid syndrome?

Accepted Answer

Not necessarily. A positive antibody test alone does not diagnose antiphospholipid syndrome. You need positive antibody testing (confirmed at least 12 weeks later) plus clinical manifestations: either a documented blood clot in a vein or artery, or pregnancy complications including recurrent miscarriage, fetal loss, or premature birth due to placental problems. If you have only positive antibodies without these clinical events, your doctor may recommend low-dose aspirin for primary prevention while monitoring you closely.

Question 2

Can I ever stop taking anticoagulation medication?

Accepted Answer

This depends on your specific situation. If you have had a thrombotic event (blood clot), you typically need long-term or lifelong anticoagulation, as stopping medication significantly increases your risk of another clot. If you take aspirin for primary prevention (positive antibodies without a prior clot), your doctor may discuss duration based on your risk factors. This decision is highly individual and should involve detailed discussion with your healthcare team about your specific circumstances.

Question 3

Is it safe to have surgery if I have antiphospholipid syndrome?

Accepted Answer

Yes, with proper planning. Before surgery, discuss your condition with your surgical and medical teams. You will likely need to adjust your anticoagulation medication before and after surgery to balance clotting and bleeding risks. Your doctors may recommend bridging anticoagulation (temporary heparin) while you are off warfarin. Detailed preoperative planning significantly reduces your surgical risk.

Question 4

Can I take hormonal birth control if I have antiphospholipid syndrome?

Accepted Answer

This requires careful discussion with your doctor. Hormonal contraceptives increase clotting risk in everyone, and this risk is substantially higher for people with antiphospholipid syndrome, particularly if you have triple positivity or prior thrombosis. Many doctors recommend alternatives such as nonhormonal IUDs, barrier methods, or permanent sterilization. If hormonal contraception seems necessary, your doctor might use it with careful monitoring and additional anticoagulation measures, but usually alternatives are preferred.

Question 5

If I plan to become pregnant, what should I do?

Accepted Answer

Planning pregnancy with antiphospholipid syndrome requires close coordination with your healthcare team before conception. You and your doctor should discuss switching from warfarin to heparin (warfarin can harm the fetus). You will likely take either low-molecular-weight heparin (LMWH) by injection or unfractionated heparin during pregnancy and after delivery. Aspirin is often continued as well. With appropriate treatment, pregnancy loss rates drop from 50-70 percent to around 20-30 percent or lower. Specialist care from maternal-fetal medicine or high-risk obstetrics significantly improves outcomes.

Question 6

What should I do if I miss a dose of my anticoagulant?

Accepted Answer

This depends on which medication you take and how long since you missed the dose. If you remember within a few hours, take the missed dose. If it is almost time for your next dose, skip the missed dose and take your next dose as scheduled. Never double up on doses. If you miss more than one dose or are unsure, contact your pharmacist or doctor. Set phone reminders or use a pill organizer to help prevent missed doses.

Question 7

Can I donate blood if I have antiphospholipid syndrome?

Accepted Answer

Most blood banks will not accept blood from people taking warfarin or other anticoagulants due to bleeding risk and concerns about the quality and safety of the donated blood. If you take low-dose aspirin for primary prevention without other anticoagulation, some facilities may accept your donation; ask your local blood bank about their specific policies.

Question 8

How does antiphospholipid syndrome affect my life expectancy?

Accepted Answer

With appropriate diagnosis and treatment, most people with antiphospholipid syndrome have a normal or near-normal life expectancy. The 10-year survival rate is 90-94 percent when properly treated. However, approximately 30 percent of people experience permanent organ damage from thrombotic events, which can affect quality of life. Prevention through consistent medication adherence and risk factor management is key to maintaining long-term health.

Question 9

Will my children inherit antiphospholipid syndrome?

Accepted Answer

Antiphospholipid syndrome is not directly inherited. If your child carries the same genetic predisposition, they might produce antiphospholipid antibodies, but antibodies alone do not cause disease. Only a small percentage of people with the antibodies develop clinical antiphospholipid syndrome. Your children should be aware of the family history, but routine screening is not recommended unless they develop symptoms suggesting thrombosis.

Question 10

Is there research into new treatments for antiphospholipid syndrome?

Accepted Answer

Yes, ongoing research is exploring new anticoagulants, anticomplement therapies, and treatments targeting the underlying immune abnormality. Some newer therapies targeting specific parts of the complement system show promise in early studies. Clinical trials may be available through the National Institutes of Health or through universities and medical centers. Ask your doctor about whether any trials might be appropriate for your situation.

Question 11

Can COVID-19 infection affect my antiphospholipid syndrome?

Accepted Answer

COVID-19 infection can temporarily elevate antiphospholipid antibody levels, which might increase your short-term clotting risk. Some evidence suggests people with antiphospholipid syndrome may have higher risk of severe COVID-19. Vaccination is strongly recommended. If you contract COVID-19, contact your healthcare team promptly, as your doctors may recommend temporary adjustments to your anticoagulation or closer monitoring.